Posted by Michael Wonder on 20 Feb 2025
Fast track granted by FDA for NNZ-2591 in Pitt Hopkins syndrome
19 February 2025 - : Neuren Pharmaceuticals today announced that the US FDA has granted fast track designation for NNZ-2591 for the treatment of Pitt Hopkins syndrome
Currently there are no treatments approved to treat Pitt Hopkins syndrome.
